HAG
HighPoint Advisor Group’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $235K | Sell |
14,160
-1,145
| -7% | -$19K | 0.02% | 463 |
|
|
2021
Q2 | $373K | Buy |
15,305
+516
| +3% | +$12.6K | 0.04% | 355 |
|
|
2021
Q1 | $302K | Buy |
14,789
+600
| +4% | +$12.3K | 0.03% | 368 |
|
|
2020
Q4 | $716K | Buy |
14,189
+5,018
| +55% | +$253K | 0.09% | 188 |
|
|
2020
Q3 | $445K | Buy |
+9,171
| New | +$445K | 0.08% | 203 |
|
|
2017
Q1 | – | Sell |
-29,980
| Closed | -$1.1M | – | 279 |
|
|
2016
Q4 | $1.1M | Buy |
+29,980
| New | +$1.1M | 0.35% | 69 |
|